ANTITUMOR COMBINATION COMPRISING OMBRABULIN AND CISPLATIN ASSOCIATED WITH RADIOTHERAPY

摘要

The invention relates to an antitumor pharmaceutical combination comprising ombrabulin or AVE8062, which may be in base form or in the form of a pharmaceutically acceptable salt and cisplatin, for its use as an antitumor agent for patients also treated by radiotherapy, especially with cancer and even more particularly with solid tumors.